ArticleCancer immunology, immunotherapy : CII2023

Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.

Claire Battin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.